GLUE is currently covered by 7 analysts with an average price target of $28.67. This is a potential upside of $19.3 (205.98%) from yesterday's end of day stock price of $9.37.
Monte Rosa Therapeutics's activity chart (see below) currently has 37 price targets and 49 ratings on display. The stock rating distribution of GLUE is 95% BUY and 5% HOLD.
Analysts' price targets on this stock were met 58.55% of the time, taking 399.18 days on average.
Highest price target for GLUE is $37, Lowest price target is $22, average price target is $28.67.
Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 06-Nov-2026. First documented stock forecast 19-Jul-2021.
Currently out of the existing stock ratings of GLUE, 1 are a HOLD (5%), 19 are a BUY (95%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Jan-2026
$25
$15.63 (166.81%)
$27
10 days ago
(06-Nov-2026)
5/9 (55.56%)
$14.43 (136.52%)
603
Buy Since 01-Oct-2026
$25
$15.63 (166.81%)
$25
1 months 11 days ago
(05-Oct-2026)
0/2 (0%)
$14.73 (143.43%)
Buy Since 15-Feb-2024
$27
$17.63 (188.15%)
$27
2 months 7 days ago
(09-Sep-2026)
3/6 (50%)
$12.74 (89.34%)
506
Buy Since 03-Jan-2022
$28
$18.63 (198.83%)
$28
2 months 22 days ago
(25-Aug-2026)
0/6 (0%)
$13.44 (92.31%)
Buy Since 11-May-2026
$27
$17.63 (188.15%)
$31
3 months 9 days ago
(07-Aug-2026)
0/2 (0%)
$11.12 (70.03%)
What is GLUE (Monte Rosa Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on GLUE (Monte Rosa Therapeutics)?
Which analyst has the most public recommendations on GLUE (Monte Rosa Therapeutics)?
Which analyst is the currently most bullish on GLUE (Monte Rosa Therapeutics)?
Which analyst is the currently most reserved on GLUE (Monte Rosa Therapeutics)?